RISK OF HEPATOCELLULAR CANCER AFTER VIROLOGICAL CURE WITH DIRECT ACTING ANTIVIRAL AGENTS IN INDIVIDUALS WITH HEPATITIS C
$800,660FY2019Defense Health AgencyDOD
The General Hospital Corporation
Investigators
View source on USAspending →RISK OF HEPATOCELLULAR CANCER AFTER VIROLOGICAL CURE WITH DIRECT ACTING ANTIVIRAL AGENTS IN INDIVIDUALS WITH HEPATITIS C · GrantIndex